Anastrozole Arimidex CAS 120511-73-1 fast delivery
Molecular formula: C17H19N5
Molecular weight: 293.36600
Precise quality: 293.16400
Appearance and properties: crystalline solids
Density: 1.08 g/cm3
Melting point: 81-82 °C
Boiling point: 469.7°C at 760 mmHg
Refractive index: 1.791
Storage conditions: Store in original container in a cool dark place.
Package level: III Anastrozole and Weight Loss
Risk category: 6.1 (b)
Customs Code: 2933990090
Dangerous goods transportation Code: 3249
Danger category code: R36/37/38
Safety instructions: S26; S37/39
Dangerous goods sign: Xi
Production methods and uses
The third generation of aromatase inhibitors. It is used to treat postmenopausal patients with advanced breast cancer.
anastrozole side effects mayo clinic
oral & injectable anabolic steroid hormones anastrozole cas 120511-73-1 male supplement with anti-estrogen arimidex
alias :arimidex ,tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl)1,3-benzenediacetionitrile
cas no. : 120511-73-1
assay : 98%~102%
appearance : white crystalline powder
active life cycle : 6 hours
mf : c17h19n5
mw : 293.37
molecular structure :
oral & injectable anabolic steroid hormones anastrozole for male bodybuilding supplement
grade : pharmaceutical grade
storage: shading, confined preservation
manufacturer : hezhong
usage : anastrozole is a potent non-steroidal aromatase inhibitors , which lead the decrease of plasma level of estrogen, inhibited the growth of breast cancer. for the treatment of advanced breast cancer in postmenopausal women patients.
anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. it is used both in adjuvant therapy (i.e. following surgery) and in metastatic breast cancer.
many breast cancers also contain aromatase; the importance of tumor-generated estrogens is uncertain. treatment of breast cancer has included efforts to decrease estrogen levels by ovariectomy premenopausally and by use of anti-estrogens and progestational agents both pre- and post-menopausally, and these interventions lead to decreased tumor mass or delayed progression of tumor growth in some women. anastrozole is a potent and selective non-steroidal aromatase inhibitor. it significantly lowers serum estradiol concentrations and has no detectable effect on formation of adrenal corticosteroids or aldosterone.
three azole aromatase inhibitors are potent selective, it can inhibit the cytochrome p-450 dependent aromatase thereby blocking the biosynthesis of estrogen, but estrogen is the main factor that stimulates the growth of breast cancer cells.
the treatment of breast cancer, especially for those with adjuvant hormone therapy after menopause after recurrence of women with advanced breast cancer.
anastrozole is more effective than previous drugs such as tamoxifen and crucially, it has fewer side effects . anastrozole has been tested for reducing estrogens, including estradiol, in men.
some athletes and body builders use anastrozole as part of their steroid cycle to reduce and prevent symptoms of excess estrogen--gynecomastia, emotional lability and water retention.
bone weakness has been associated with anastrozole.